Article info

Download PDFPDF

293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer

Authors

Citation

Protheroe NA, DellaGrotte K, Kantamneni H, et al
293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer

Publication history

  • First published October 31, 2023.
Online issue publication 
October 31, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.